MIST Straddle Strategy
MIST (Milestone Pharmaceuticals Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans. The company was incorporated in 2003 and is headquartered in Montréal, Canada.
MIST (Milestone Pharmaceuticals Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $147.7M, a beta of 1.04 versus the broader market, a 52-week range of 1-3.06, average daily share volume of 2.0M, a public-listing history dating back to 2019, approximately 33 full-time employees. These structural characteristics shape how MIST stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.04 places MIST roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a straddle on MIST?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
Current MIST snapshot
As of May 15, 2026, spot at $1.50, ATM IV 65.50%, IV rank 12.05%, expected move 18.78%. The straddle on MIST below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this straddle structure on MIST specifically: MIST IV at 65.50% is on the cheap side of its 1-year range, which favors premium-buying structures like a MIST straddle, with a market-implied 1-standard-deviation move of approximately 18.78% (roughly $0.28 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MIST expiries trade a higher absolute premium for lower per-day decay. Position sizing on MIST should anchor to the underlying notional of $1.50 per share and to the trader's directional view on MIST stock.
MIST straddle setup
The MIST straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MIST near $1.50, the first option leg uses a $1.50 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MIST chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MIST shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $1.50 | N/A |
| Buy 1 | Put | $1.50 | N/A |
MIST straddle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
MIST straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on MIST. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use straddle on MIST
Straddles on MIST are pure-volatility plays that profit from large moves in either direction; traders typically buy MIST straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
MIST thesis for this straddle
The market-implied 1-standard-deviation range for MIST extends from approximately $1.22 on the downside to $1.78 on the upside. A MIST long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current MIST IV rank near 12.05% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on MIST at 65.50%. As a Healthcare name, MIST options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MIST-specific events.
MIST straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MIST positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MIST alongside the broader basket even when MIST-specific fundamentals are unchanged. Always rebuild the position from current MIST chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on MIST?
- A straddle on MIST is the straddle strategy applied to MIST (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With MIST stock trading near $1.50, the strikes shown on this page are snapped to the nearest listed MIST chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are MIST straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the MIST straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 65.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a MIST straddle?
- The breakeven for the MIST straddle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current MIST market-implied 1-standard-deviation expected move is approximately 18.78%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on MIST?
- Straddles on MIST are pure-volatility plays that profit from large moves in either direction; traders typically buy MIST straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current MIST implied volatility affect this straddle?
- MIST ATM IV is at 65.50% with IV rank near 12.05%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.